Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05758545 · ClinicalTrials.gov registry record · NA
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
A NA study of Diabetic Foot Ulcer, sponsored by Piomic Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 20
- Study locations
NCT05758545 is a NA study of Diabetic Foot Ulcer that is actively recruiting participants, run by Piomic Medical. The registered enrollment target is 450 participants, above the 248-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (81% higher). The trial reports 20 study locations across 5 states.
The verdict
NCT05758545, a NA study of Diabetic Foot Ulcer, is actively recruiting participants, sponsored by Piomic Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this clinical trial is to evaluate the safety and effectiveness of the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, sham-controlled trial is designed to demonstrate superiority of wound closure of the COMS One device to a sham-control device through 24 weeks post-application, when each is administered in conjunction with standard of care (SOC) in the treatment of DFUs.
Conditions Studied
Interventions
- DEVICE Sham device
- DEVICE COMS One device
Study Locations (20)
California
- Center for Clinical Research Inc. - Castro Valley
- VA Central California Healthcare - Fresno
- Limb Preservation Platform, Inc. - Fresno
- Angel City Research, Inc. - Los Angeles
- UCLA Ronald Regan - Department of Surgery - Los Angeles
- Center for Clinical Research Inc. - San Francisco
- Center for Clinical Research Inc. - San Francisco
- ILD Research Center - Vista
Florida
- Bay Pines VA Healthcare System - Bay Pines
- MCR Health - Bradenton
- University of Florida Health Jacksonville - Jacksonville
- Clever Medical Research LLC - Miami
- The Angel Medical Research Corporation - Miami Lakes
- Vital Medical Research - Sweetwater
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
- Rush University - Chicago
- Gateway Clinical Trials - O'Fallon
Arizona
- Titan Clinical Research - Mesa
- Southern Arizona VA Health Care System - Tucson
Georgia
- Aiyan Diabetes Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2027-06-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05758545
The ClinicalTrials.gov registry entry for NCT05758545 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 248-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (81% higher). The listed sponsor is Piomic Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Sham device is the first listed.
NCT05758545 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05758545 about?
NCT05758545 is a clinical study titled "Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers". The purpose of this clinical trial is to evaluate the safety and effectiveness of the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, sham-controlled trial is designed to demonstrate superiority of wound closure ...
What is the current status of trial NCT05758545?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2023-06-19. Estimated completion is 2027-06-19.
What conditions does trial NCT05758545 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT05758545?
The interventions under investigation include: Sham device (DEVICE), COMS One device (DEVICE).
Who is sponsoring clinical trial NCT05758545?
This trial is sponsored by Piomic Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05758545 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.